Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Epigenetic Modifications and Targeted Therapy in Pediatric Acute Myeloid Leukemia

Version 1 : Received: 1 June 2022 / Approved: 3 June 2022 / Online: 3 June 2022 (10:59:28 CEST)

How to cite: Xu, H.; Wen, Y.; Jin, R.; Chen, H. Epigenetic Modifications and Targeted Therapy in Pediatric Acute Myeloid Leukemia. Preprints 2022, 2022060046. https://doi.org/10.20944/preprints202206.0046.v1 Xu, H.; Wen, Y.; Jin, R.; Chen, H. Epigenetic Modifications and Targeted Therapy in Pediatric Acute Myeloid Leukemia. Preprints 2022, 2022060046. https://doi.org/10.20944/preprints202206.0046.v1

Abstract

Acute myeloid leukemia (AML) is a hematological malignancy that is the culmination of genetic and epigenetic alterations in the hematopoietic progenitor cells, leading to uncontrolled proliferation at the expense of normal hematopoiesis and bone marrow exhaustion. Although the outcomes for pediatric AML have improved in recent decades, at least one third of children still have relapses. Recent studies have notably highlighted the important role of dysregulated epi-genetic mechanisms in myeloid leukemogenesis. Epigenetic modifications are frequently reversible compared to genetic alterations, thus providing opportunities for targeted epigenetic therapy. In this review, we summarize the landscape of epigenetic alterations and the progress to date in epigenetic targeted therapy, and focus on the future role of epigenetic abnormalities in predicting relapse and the precision therapy in pediatric AML.

Keywords

Acute myeloid leukemia; Pediatric; Epigenetics; DNA methylation; Histone modification; Non-coding RNAs; Therapy

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.